PICOGRAM-EYESEL-China OriginCell Technology Group signs three-way business agreement...Entering Global Markets such as China
[Seoul =NewsPim] Reporter KimYang-Seop= Picogram (CEO ChoiSuk Rim) announced on the 12th that it has signed a three-way business agreement with ShanghaiOCellBiotech Co., Ltd., a subsidiary of China's Origin Cell Technology Group, withEYESEL.
This agreement was signed for the purpose of developing, producing, and distributing innovative cell-based cosmetics, and is a broad strategic framework agreement that includes three-way technology exchanges and employee training.
Through this business agreement,PICOGRAMplans to accelerate research on the development and technology ofEYESELand cell-based, which recently acquired some shares (12.7%) and accelerate its entry into global markets, including China.
Choi Suk Rim,CEO of Picogram, said, "We expect the three-way business agreement to be a bridgehead for China's rapidly growing cell-based cosmetics market."
CEO Choi added, "With this agreement, we have agreed to gradually strengthen cooperation in equipment such as ultra-low temperature cell storage facilities with the leading state-of-the-art automation and unmanned 5G cell banks established by Origin Cell Technology Group."
[Source : NewsPim]
No | Title | Author | Date |
---|---|---|---|
2 | PICOGRAM-EYESEL-China OriginCell Technology Group signs three-way business agreement...Entering Global Markets such as China | CELLINstem | 2023-11-02 |
1 | [News] PICOGRAM Acquires Stake in EYESEL to Expand Business in Bio and Healthcare Fields | CELLINstem | 2023-09-21 |